150 Participants Needed

Diet and Exercise for Peripheral Artery Disease

Recruiting at 1 trial location
AG
Overseen ByAndrew Gardner, Ph.D.
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: University of Oklahoma
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial tests the effectiveness of combining the DASH diet with a home-based exercise plan for individuals with peripheral artery disease (PAD). The goal is to determine if this combination can enhance walking ability and blood flow. Participants will either follow the exercise plan alone or both the diet and exercise. Individuals who have experienced claudication (leg pain while walking) and have PAD may be suitable candidates. As an unphased trial, this study provides participants the chance to contribute to valuable research that could enhance PAD management strategies.

Will I have to stop taking my current medications?

The trial does not specify if you need to stop taking your current medications, but you cannot participate if you started taking cilostazol or pentoxifylline for intermittent claudication within the last three months.

Is there any evidence suggesting that this trial's treatments are likely to be safe?

Research has shown that the DASH diet and home-based exercise programs are generally safe for most people, including those with peripheral artery disease (PAD). The DASH diet, which promotes eating more fruits, vegetables, and whole grains, is linked to a lower risk of heart problems and is well-tolerated by most individuals.

Researchers have tested home-based exercise programs in people with PAD, demonstrating that these programs help participants walk farther and faster without causing major issues. These exercises are considered safe and effective for many with PAD.

Both components of the trial treatment are supported by evidence showing they are safe and can positively impact health.12345

Why are researchers excited about this trial?

Researchers are excited about these treatments for Peripheral Artery Disease (PAD) because they focus on lifestyle changes rather than medications or surgical interventions, which are often the standard approaches. The DASH Diet plus Home-Based Exercise uniquely combines dietary changes with exercise, emphasizing fruits, vegetables, whole grains, and low-fat dairy to improve overall cardiovascular health. The Home-Based Exercise program offers flexibility, allowing patients to manage their condition through regular, moderate-intensity walking in the comfort of their own homes. These approaches aim to empower patients to take control of their health with potentially fewer side effects and a more sustainable long-term impact.

What evidence suggests that this trial's treatments could be effective for PAD?

Research has shown that both the DASH diet and home exercise can help treat Peripheral Artery Disease (PAD). In this trial, one group of participants will follow the DASH diet, which includes plenty of fruits, vegetables, whole grains, and low-fat dairy, and is linked to better heart health. When combined with exercise, this diet can enhance exercise capacity and quality of life for people with PAD. Another group in the trial will focus on a home-based exercise program. Home walking programs have been found to significantly increase the distance and speed at which people with PAD can walk. Regular exercise is often recommended to improve walking ability and overall fitness in people with PAD.12346

Who Is on the Research Team?

AG

Andrew Gardner, Ph.D.

Principal Investigator

Professor, Department of Medicine, Cardiology

Are You a Good Fit for This Trial?

This trial is for individuals with Peripheral Artery Disease (PAD), specifically those who have leg pain during walking, and have either abnormal ankle-brachial index (ABI) readings or a history of procedures to improve blood flow. It's not for people without PAD, those with severe PAD symptoms like rest pain or tissue loss, recent revascularization, active cancer, certain chronic conditions, cognitive dysfunction, or on recent claudication medication.

Inclusion Criteria

I have peripheral artery disease (PAD) confirmed by a test or past treatment.
I have poor circulation in my legs, confirmed by a test or previous surgery.
I have experienced leg pain from walking.

Exclusion Criteria

I started taking medication for leg pain when walking in the last 3 months.
You have medical conditions that make it unsafe for you to exercise, as determined by the American College of Sports Medicine.
I have severe tissue loss due to poor blood flow in my legs.
See 8 more

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants follow a combined DASH dietary program and home-based exercise program, or a home-based exercise program alone, for 3 months

12 weeks
Weekly self-reported monitoring

Follow-up

Participants are monitored for changes in exercise and vascular outcomes after the intervention

4 weeks

What Are the Treatments Tested in This Trial?

Interventions

  • DASH Diet plus Home-Based Exercise
  • Home-Based Exercise
Trial Overview The study tests if a specific diet called the DASH Diet combined with home-based exercise improves physical function in PAD patients. Participants are randomly assigned to follow this regimen or just the exercise program for three months while their steps and vascular health are monitored.
How Is the Trial Designed?
2Treatment groups
Experimental Treatment
Active Control
Group I: DASH Diet plus Home-Based ExerciseExperimental Treatment1 Intervention
Group II: Home-Based ExerciseActive Control1 Intervention

DASH Diet plus Home-Based Exercise is already approved in United States for the following indications:

🇺🇸
Approved in United States as DASH Dietary Program for:

Find a Clinic Near You

Who Is Running the Clinical Trial?

University of Oklahoma

Lead Sponsor

Trials
484
Recruited
95,900+

Milton S. Hershey Medical Center

Collaborator

Trials
515
Recruited
2,873,000+

National Institute on Aging (NIA)

Collaborator

Trials
1,841
Recruited
28,150,000+

Case Western Reserve University

Collaborator

Trials
314
Recruited
236,000+

Published Research Related to This Trial

Exercise therapy significantly improves ambulatory outcomes and reduces leg symptoms in patients with peripheral artery disease (PAD), enhancing their functional independence and quality of life.
The review emphasizes the importance of detailed exercise prescriptions in future trials to better quantify the total exercise dose, which could lead to more effective treatment strategies for PAD.
Exercise rehabilitation for peripheral artery disease: An exercise physiology perspective with special emphasis on the emerging trend of home-based exercise.Gardner, AW.[2022]
A home-based walking exercise intervention led by physical therapists significantly improved the 6-minute walking distance in adults with peripheral artery disease (PAD) after 3 months, with an average increase of 16.7 meters compared to usual care.
Despite 13 serious adverse events reported in the intervention group, all were deemed unrelated to the study, indicating that the intervention was safe for participants.
Effect of a Home-Based, Walking Exercise Behavior Change Intervention vs Usual Care on Walking in Adults With Peripheral Artery Disease: The MOSAIC Randomized Clinical Trial.Bearne, LM., Volkmer, B., Peacock, J., et al.[2022]
Home-based cardiac rehabilitation, using a nurse-facilitated self-help package over 6 weeks, was found to be slightly less expensive than traditional hospital-based rehabilitation, primarily due to lower personnel costs.
Both home-based and hospital-based rehabilitation showed similar overall healthcare costs and quality of life outcomes over 9 months, indicating that home-based programs can be a cost-effective alternative without compromising patient health benefits.
Home-based cardiac rehabilitation versus hospital-based rehabilitation: a cost effectiveness analysis.Taylor, RS., Watt, A., Dalal, HM., et al.[2022]

Citations

The Effects of Diet and Exercise Interventions in Peripheral ...This study is a 3-month, prospective, randomized controlled clinical trial designed to address the efficacy of the DASH dietary program combined with a ...
The Effects of Diet and Exercise Interventions in Peripheral ...We propose to test the efficacy of a modDASH dietary program combined with an exercise program (modDASH+Ex) to improve exercise and vascular outcome measures in ...
Diet and Exercise for Peripheral Artery DiseaseTrial Overview The study tests if a specific diet called the DASH Diet combined with home-based exercise improves physical function in PAD patients.
DASH Dietary Pattern and Cardiometabolic OutcomesConclusions: Current evidence allows for the conclusion that the DASH dietary pattern is associated with decreased incidence of cardiovascular disease and ...
The Effects of Diet and Exercise Interventions in Peripheral ...Our central hypothesis is that the modDASH+Ex program improves the efficacy to rehabilitate PAD patients by improving exercise outcomes, health-related quality ...
Effects of the DASH Diet Alone and in Combination With ...Effects of the DASH Diet Alone and in Combination With Exercise and Weight Loss on Blood Pressure and Cardiovascular Biomarkers in Men and Women ...
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security